Literature DB >> 15381339

Prevalence of anemia in skilled-nursing home residents.

Andrew S Artz1, Dean Fergusson, Paul J Drinka, Melvin Gerald, Stefan Gravenstein, Anthony Lechich, Felix Silverstone, Shanda Finnigan, Mark C Janowski, Mark A McCamish, William B Ershler.   

Abstract

Anemia is a frequent problem among older persons, the prevalence of which may be particularly high in skilled-nursing facilities but recent data in this regard is lacking. The purpose of this study was to define the prevalence of anemia and its association with hospitalization in skilled-nursing home residents. We retrospectively reviewed randomly selected charts among five skilled-nursing facilities within the National Geriatrics Research Consortium (NGRC). Among 900 chronically residing patients with completed chart information, the mean and median ages were 79 years and 82 years, respectively. Eighty-seven percent of patients were 65 years or greater. Applying the World Health Organization criteria for anemia (hemoglobin <12 g/dl for women and hemoglobin <13 g/dl for men), we found a 6-month point prevalence of 48%. The hospitalization rate was higher among those with more severe anemia. Few residents were treated with recombinant erythropoietin therapy or red blood cell transfusion. Anemia is very common in the nursing home, and despite being associated with increased morbidity; it is, for the most part, untreated in this setting. With an increased understanding of erythropoiesis and the availability of recombinant growth factors, future studies should evaluate the causes and potential benefits of treatment in terms of quality of life, reduced morbidity and health economics.

Entities:  

Mesh:

Year:  2004        PMID: 15381339     DOI: 10.1016/j.archger.2004.03.006

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  17 in total

Review 1.  Epidemiology of anemia in older adults.

Authors:  Kushang V Patel
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

Review 2.  Unexplained anemia in the elderly.

Authors:  Sasan Makipour; Bindu Kanapuru; William B Ershler
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

3.  Assessing the quality of prescribing and monitoring erythropoiesis-stimulating agents in the nursing home setting.

Authors:  An-Kwok I Wong; Scott B Stephens; Monica B Aspinall; Shyam Visweswaran; Joseph T Hanlon; Steven M Handler
Journal:  J Am Med Dir Assoc       Date:  2009-07       Impact factor: 4.669

Review 4.  New challenges in evaluating anemia in older persons in the era of molecular testing.

Authors:  David P Steensma
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 5.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

6.  BONE MARROW, THYMUS AND BLOOD: CHANGES ACROSS THE LIFESPAN.

Authors: 
Journal:  Aging health       Date:  2009-06-01

Review 7.  Anaemia in the older surgical patient: a review of prevalence, causes, implications and management.

Authors:  Judith Partridge; Danielle Harari; Jessica Gossage; Jugdeep Dhesi
Journal:  J R Soc Med       Date:  2013-06-06       Impact factor: 5.344

8.  Anemia Prevalence and Trends in Adults Aged 65 and Older: U.S. National Health and Nutrition Examination Survey: 2001-2004 to 2013-2016.

Authors:  Amy E Seitz; Mark S Eberhardt; Susan L Lukacs
Journal:  J Am Geriatr Soc       Date:  2018-09-24       Impact factor: 5.562

9.  Multiple myeloma in the very old: an IASIA conference report.

Authors:  Sascha A Tuchman; Gary R Shapiro; William B Ershler; Ashraf Badros; Harvey J Cohen; Angela Dispenzieri; Irene Q Flores; Bindu Kanapuru; Donald Jurivich; Dan L Longo; Ali Nourbakhsh; Antonio Palumbo; Jeremy Walston; Jerome W Yates
Journal:  J Natl Cancer Inst       Date:  2014-04-03       Impact factor: 13.506

10.  Falls in nursing home residents receiving pharmacotherapy for anemia.

Authors:  Gregory Reardon; Naushira Pandya; Robert A Bailey
Journal:  Clin Interv Aging       Date:  2012-10-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.